The Insides Company

28/10/2025

We are delighted to share our first Malaysian patient case study, presented at MUGIS 2025 in Kuala Lumpur.

The case details a 31-year-old’s recovery from typhoid-related small-bowel obstruction using The Insides System.

We extend our sincere thanks to the teams at Hospital Sultanah Aminah and Hospital UKM for sharing their valuable experience.

An inspiring story of intestinal rehabilitation and full recovery using The Insides System. hashtag

To enquire about The Insides System in Malaysia, please contact our local distributor Medi-Life (M) Sdn Bhd.

https://www.theinsides.co/posters/mugis-2025

17/10/2025

We’re proud to be featured alongside fellow New Zealand innovators who are transforming global health with leading medical technologies.

At The Insides Company, our mission is to provide universal access to chyme reinfusion therapy through revolutionary products and education to establish a new standard of care for patients with intestinal failure.

Thank you to New Zealand Trade and Enterprise (NZTE) for including The Insides Company in this video. Together with Alimetry and Aroa Biosurgery, we’re shaping a healthier future driven by science, compassion, and innovation.

12/10/2025

We’re proud to share that The Insides System has been officially registered with the Malaysia Medical Device Authority (MDA) — a key regulatory milestone as we expand into Southeast Asia.

This approval enables the official distribution of The Insides System in Malaysia, bringing us one step closer to delivering global access to chyme reinfusion therapy for intestinal failure and rehabilitation.

If you are interested in introducing chyme reinfusion therapy into your practice in Malaysia, or would like to learn more, please contact our local distributor, Medi-Life.

Read more:

The Insides Company is pleased to announce the registration of The Insides System under the Malaysia Medical Device Authority (MDA).

10/10/2025

A new open-access case report has been published in the New Zealand Medical Journal (Vol. 138 No. 1623, 10 Oct 2025):

“Distant stoma chyme reinstallation—the first use of The Insides® Channel.”

This report describes a 72-year-old patient—the first to receive chyme reinstallation from one stoma to a second, distant stoma using The Insides Channel device.

Read the full paper (open access): https://nzmj.org.nz/journal/vol-138-no-1623/distant-stoma-chyme-reinstallation-the-first-use-of-the-insides-channel

10/09/2025

The countdown is on for the 47th ESPEN Congress in Prague, 13–16 September 2025.

Meet our partner GBUK Group to discover The Insides System and learn how chyme reinfusion therapy is helping to improve outcomes for patients with intestinal failure.

Looking forward to connecting in Prague!

07/09/2025

Only days to go until CIIRTA 2025 – 10 Sept in Gothenburg, Sweden.
Join us as our Swedish partner Kebomed exhibits The Insides System and The Insides Channel, showing how chyme reinfusion therapy supports intestinal rehabilitation.

04/09/2025

Jaybie’s Journey – First Home Use of The Insides Neo in New Zealand

Born preterm with gastroschisis, Jaybie required multiple surgeries and developed intestinal failure, relying on intravenous nutrition for survival. Her recovery included successful chyme reinfusion therapy with The Insides Neo—first in hospital, and then, for the first time in New Zealand, at home.
This milestone marks a significant step forward in enabling safe, patient-managed chyme reinfusion therapy for paediatric patients outside a hospital setting. It reflects the dedication of her clinical team, her family’s commitment, and the potential of innovative technology to transform lives.

Click to read: https://www.theinsides.co/case-studies/jaybies-story

This case study follows Jaybie, a preterm infant born with gastroschisis who required multiple abdominal surgeries and experienced a complex postoperative course. She developed intestinal failure, became dependent on intravenous nutrition, and faced a long and challenging path to discharge...

03/09/2025

The Insides team is looking forward to the 47th ESPEN Congress, 13–16 September 2025 in Prague, Czech Republic.
ESPEN is a leading forum for global experts in clinical nutrition and metabolism. Our partner GBUK Group will be exhibiting The Insides System, highlighting chyme reinfusion therapy for improving outcomes in intestinal failure.

See you in Prague!

01/09/2025

We’re looking forward to CIIRTA 2025 on 10th of September in Gothenburg, Sweden — the XIX Congress of the International Intestinal Rehabilitation and Transplantation Association.
Our partner Kebomed will be exhibiting The Insides System and The Insides Channel, showcasing how chyme reinfusion therapy supports intestinal rehabilitation.
CIIRTA brings together leading clinicians, surgeons, allied health professionals, and researchers from around the world to share insights, advance innovation, and explore the “True North” in intestinal rehabilitation and transplantation.

See you in Gothenburg!

22/08/2025

Mandla, a patient at Charlotte Maxeke Hospital in Johannesburg, faced severe weight loss from high-output stoma losses.

With The Insides System—and thanks to the dedication of our South Africa distribution partner First Medical Company and Hilda —Mandla has regained weight, restored his nutritional status, and improved his health.

This outcome highlights the power of chyme reinfusion therapy and the critical role our partners play in delivering life-changing technology to patients in need. We’re grateful for First Medical Company’s commitment to improving patient care in South Africa.

Watch the patient testimonial: https://www.youtube.com/watch?v=rsP1rIkMK-U

20/08/2025

We’re participating in the Enteric Fistula and Open Abdomen (EFOA) 2025 on 28–29 August, in Copenhagen, Denmark.
Please listen to Prof. Ian Bissett present on “Chyme reinfusion for entero-atmospheric fistula: challenges, lessons, and outcomes of a national experience”— at 11:40am Friday 29th August

We look forward to connecting with you at the stand with our distribution partner, Kebomed!

09/07/2025

When little Isabella was born at just 30 weeks, her whānau faced a terrifying journey that is incredibly hard for any parents to walk. Fortunately, The Insides Neo was able to help, and Isabella not only survived but is now thriving.
We are deeply grateful to Danielle and Andrew for bravely sharing their story. Your courage will help so many other families facing similar challenges.
A heartfelt thank you to Cure Kids for funding the research that made this innovation possible, and to Cure Kids Ventures for enabling The Insides to take this life-changing technology to the world.
To the extraordinary team at the Auckland Hospital NICU and Starship Foundation - thank you for your tireless dedication, skill, and compassion. You are true heroes.
Read the full story below from the Eastern Bays Courier (June 25, 2025) below to see how this Kiwi innovation is changing lives.

https://www.pressreader.com/new-zealand/eastern-bays-courier/20250625/page/1

Eastern Bays Courier